Westlake Chemical Partners downgraded by BofA Securities with a new price target
$WLKP
Major Chemicals
Industrials
BofA Securities downgraded Westlake Chemical Partners from Buy to Underperform and set a new price target of $27.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/2/2022 | $30.00 → $31.00 | Buy | Deutsche Bank |
| 7/16/2021 | $27.00 | Buy → Underperform | BofA Securities |
Westlake Chemical Partners (NYSE:WLKP) today announced that Ms. Lisa A. Friel has been appointed to the board of directors of its general partner, Westlake Chemical Partners GP LLC. She will replace Ms. Angela A. Minas, who previously informed the company that she would resign from the board effective upon the appointment of her successor. Ms. Friel was the Managing Partner of Ernst & Young LLP's San Antonio, Texas office from July 2012 until her retirement in September 2020. Ms. Friel began her career with Ernst & Young LLP in 1988. She is currently the Chair of the Board of Directors for the United Way of San Antonio. Ms. Friel holds a bachelor's of science degree in Accounting and Busi
Retirement of Dr Sarah Ryan and Dr Christopher Haynes from the Woodside BoardPERTH, AUSTRALIA / ACCESSWIRE / March 8, 2023 / The Board of Woodside announces the retirement of Dr Sarah Ryan and Dr Christopher Haynes as Directors of Woodside. Dr Ryan and Dr Haynes will be standing down from their respective offices with effect from the conclusion of Woodside's 2023 Annual General Meeting, scheduled to be held on 28 April 2023 (2023 AGM).Dr Haynes has served on Woodside's Board since 2011 and is a member of the Audit & Risk Committee, the Sustainability Committee and the Nominations & Governance Committee.Dr Ryan joined the Woodside Board in December 2012 and serves on the Audit & Risk Committe
Crestwood Equity Partners LP (NYSE:CEQP) ("Crestwood") announced today that Angela A. Minas and Clay C. Williams have been appointed to serve on the Board of Directors of its general partner effective January 1, 2022. "I am pleased to welcome Angela and Clay to the Crestwood Board of Directors. Both of these highly regarded individuals bring a wealth of U.S. and global industry experience and perspective to our boardroom that will greatly benefit Crestwood as we navigate the dynamic energy industry and take advantage of opportunities to continue building a leading midstream infrastructure company," said Robert G. Phillips, Chairman, President and Chief Executive Officer of Crestwood's gene
Celebrated 10th anniversary as a publicly traded master limited partnership having grown the quarterly distribution 71% since IPO Declared quarterly distribution of $0.4714 per unit; 41st consecutive quarterly distribution Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") today reported net income attributable to the Partnership in the third quarter of 2024 of $18.1 million, or $0.51 per limited partner unit, an increase of $4.9 million compared to the third quarter 2023 net income of $13.2 million. Cash flows from operating activities in the third quarter of 2024 were $126.1 million, an increase of $25.2 million compared to third quarter 2023 cash flows from operating acti
Westlake Chemical Partners (NYSE:WLKP) will release its third quarter 2024 earnings prior to the market opening on Tuesday, November 5, 2024. The company will host a conference call at 1:00 p.m. Eastern Time (12:00 p.m. Central Time) on the same day to discuss the earnings release. To access the conference by phone, it is necessary to pre-register at https://register.vevent.com/register/BId643f8e14d904c4dbc8954f14daeb022. Once registered, you will receive a phone number and unique PIN number. When you dial in, you will input the PIN number to be placed into the call. The conference call and replay will be available via webcast at https://edge.media-server.com/mmc/p/sdd3kqrb and the earnin
Declared quarterly distribution of $0.4714 per unit; 40th consecutive quarterly distribution Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") today reported net income attributable to the Partnership in the second quarter of 2024 of $14.4 million, or $0.41 per limited partner unit, an increase of $2.5 million compared to the second quarter 2023 net income of $11.9 million. Cash flows from operating activities in the second quarter of 2024 were $121.9 million, an increase of $23.4 million compared to second quarter 2023 cash flows from operating activities of $98.5 million, due to higher net income. For the three months ended June 30, 2024, MLP distributable cash flow was $1
SC 13D/A - Westlake Chemical Partners LP (0001604665) (Subject)
SC 13G/A - Westlake Chemical Partners LP (0001604665) (Subject)
SC 13G/A - Westlake Chemical Partners LP (0001604665) (Subject)
Celebrated 10th anniversary as a publicly traded master limited partnership having grown the quarterly distribution 71% since IPO Declared quarterly distribution of $0.4714 per unit; 41st consecutive quarterly distribution Westlake Chemical Partners LP (NYSE:WLKP) (the "Partnership") today reported net income attributable to the Partnership in the third quarter of 2024 of $18.1 million, or $0.51 per limited partner unit, an increase of $4.9 million compared to the third quarter 2023 net income of $13.2 million. Cash flows from operating activities in the third quarter of 2024 were $126.1 million, an increase of $25.2 million compared to third quarter 2023 cash flows from operating acti
$0.4714 per unit distribution declared payable on November 27, 2024 The Board of Directors of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP (the "Partnership") (NYSE:WLKP), has declared a distribution of $0.4714 per unit. This is the 41st quarterly distribution announced by the Partnership since its initial public offering. The distribution will be payable on November 27, 2024, to unit holders of record on November 12, 2024. This release is intended to be a qualified notice under Treasury Regulation Section 1.1446-4(b). Brokers and nominees should treat one hundred percent (100.0%) of the Partnership's distributions to non-U.S. investors as bein
Westlake Chemical Partners (NYSE:WLKP) will release its third quarter 2024 earnings prior to the market opening on Tuesday, November 5, 2024. The company will host a conference call at 1:00 p.m. Eastern Time (12:00 p.m. Central Time) on the same day to discuss the earnings release. To access the conference by phone, it is necessary to pre-register at https://register.vevent.com/register/BId643f8e14d904c4dbc8954f14daeb022. Once registered, you will receive a phone number and unique PIN number. When you dial in, you will input the PIN number to be placed into the call. The conference call and replay will be available via webcast at https://edge.media-server.com/mmc/p/sdd3kqrb and the earnin
4 - Westlake Chemical Partners LP (0001604665) (Issuer)
4 - Westlake Chemical Partners LP (0001604665) (Issuer)
4 - Westlake Chemical Partners LP (0001604665) (Issuer)
Deutsche Bank reiterated coverage of Westlake Chemical with a rating of Buy and set a new price target of $31.00 from $30.00 previously
BofA Securities downgraded Westlake Chemical Partners from Buy to Underperform and set a new price target of $27.00
UBS downgraded Westlake Chemical from Buy to Neutral and set a new price target of $25.00 from $23.00 previously
Westlake Chemical (NYSE:WLKP) reported quarterly earnings of $0.42 per share which missed the analyst consensus estimate of $0.43 by 2.33 percent. The company reported quarterly sales of $284.673 million which beat the analyst consensus estimate of $281.000 million by 1.31 percent. This is a 7.48 percent decrease over sales of $307.677 million the same period last year.
Although U.S. stocks closed mostly lower on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision. Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform. Sow Good The Trade: Sow Good Inc. (OTC:SOWG) Director Lyle Berman acquired a total of 68,966 shares an average price of
4 - Westlake Chemical Partners LP (0001604665) (Issuer)
4 - Westlake Chemical Partners LP (0001604665) (Issuer)
4 - Westlake Chemical Partners LP (0001604665) (Issuer)
10-Q - Westlake Chemical Partners LP (0001604665) (Filer)
8-K - Westlake Chemical Partners LP (0001604665) (Filer)
10-Q - Westlake Chemical Partners LP (0001604665) (Filer)